Pfizer

Stories 61 - 80 | << Prev   Next >>

Israel Has Bad News for Pfizer Vaccine

Its efficacy drops against Delta variant, but it was still 93% effective at preventing severe disease

(Newser) - Israel's Ministry of Health says the Pfizer-BioNTech vaccine isn't offering the same level of protection against COVID-19 now that the Delta variant is dominant. In May, when the Alpha variant dominated Israel, the vaccine was found to be 95.3% effective against infection, per CNN . But in a...

Pfizer, Moderna Recipients May Not Need Boosters
Pfizer, Moderna Recipients
May Not Need Boosters
new study
Jun 28, 2021 1:23 PM CDT

Pfizer, Moderna Recipients May Not Need Boosters

Study suggests the mRNA vaccines provide years of evolving protection from COVID

(Newser) - Anyone who received a double dose of either the Pfizer or Moderna vaccines may not need a booster shot anytime soon. A new study in Nature suggests that the mRNA vaccines provide years of protection—maybe even a lifetime of it, reports the New York Times . One big caveat: The...

What's Set to Be 'Biggest-Selling Medicine Ever' Had Bumpy Start

Inside Pfizer's journey to manufacture its COVID-19 vaccine

(Newser) - Pfizer is a household name thanks to its COVID-19 vaccine, of which it expects to produce as many as 3 billion doses this year. That would translate into $26 billion in sales, which would make it the "biggest-selling medicine ever," reports Christopher Rowland in a lengthy piece for...

Vaccine Cocktail Might Work: Researchers

Some countries recommend switching brands for the second dose

(Newser) - Can you mix and match two-dose COVID-19 vaccines? It's likely safe and effective, but researchers are still gathering data to be sure. The authorized COVID-19 shots around the world are all designed to stimulate your immune system to produce virus-fighting antibodies, though the way they do so varies, noted...

Delta Variant of Virus Is Spreading Quickly

It's gone beyond India, and Dr. Fauci is worried about numbers growing in the US

(Newser) - A COVID-19 variant first identified in India is spreading well beyond and risking the relative comfort that has come with vaccine rollouts in the US. The Delta variant, B.1.617.2, is now the dominant strain in the UK, making up more than 60% of cases in some areas,...

Vaccine May Be Ready for Youngest by Fall

Testing to include children 6 months to 12

(Newser) - Pfizer and Moderna are testing their coronavirus vaccines in children under 12, in a process that could have doses ready for US recipients as young as 6 months old by fall. Pfizer said Tuesday that it's starting its tests with children as young as 5 and will add younger...

Report: US to Buy 500M Pfizer Doses to Share With World

Biden expected to make announcement Thursday

(Newser) - The US will buy 500 million more doses of the Pfizer COVID-19 vaccine to share through the global COVAX alliance for donation to 92 lower income countries and the African Union over the next year, the AP reports, citing "a person familiar with the matter." President Joe Biden...

New Report Details Possible Rare Side Effect of COVID Vaccine

Teens are showing heart inflammation after 2nd dose, CDC says there's still no definite link

(Newser) - Health authorities are trying to determine whether heart inflammation that can occur along with many types of infections could also be a rare side effect in teens and young adults after the second dose of COVID-19 vaccine. An article on seven US teen boys in several states, published online in...

CDC Says Vaccines May Lead to Heart Issue in Young

More research is needed

(Newser) - A small number of teen and young adult recipients of mRNA-based coronavirus vaccines have developed a heart issue, per the New York Times . The incidence of myocarditis, or inflammation of the heart muscle, has occurred frequently enough to get the attention of the CDC, though. In a statement, the CDC...

Vaccine Booster Shots Might Be Needed By Fall

Fauci agrees they'll be needed, but we don't know when

(Newser) - There's no sign that the protection from the COVID-19 vaccines is fading for anyone yet, but the Pfizer and Moderna chief executives said we can expect to have a third shot before long. The data are showing "there will be a need for a booster somewhere between eight...

Delaying 2nd Pfizer Shot Might Pay Off
Delaying 2nd Pfizer Shot
Might Pay Off
new study
May 14, 2021 1:48 PM CDT

Delaying 2nd Pfizer Shot Might Pay Off

Study suggests waiting 12 weeks instead of 3 increases antibodies in older patients

(Newser) - Most people who get the first dose of the Pfizer vaccine receive their second shot three weeks later. A new UK study, however, suggests that waiting 12 weeks might be a better option, reports Nature . The study, which has not yet been peer reviewed, looked only at subjects over the...

CDC Advisers Say Pfizer Is Good for Kids 12 and Up

In study, none who had shots got COVID and side effects were similar to those of adults

(Newser) - US health advisers endorsed use of Pfizer's COVID-19 vaccine in kids as young as 12 on Wednesday The sprint to vaccinate millions of middle and high school students has already started in parts of the country, as a long line of kids rolled up their sleeves in suburban Atlanta...

Health Worker Accidentally Gets a 'Massive' Vaccine Dose

Italian woman is doing fine regardless

(Newser) - A 23-year-old Italian woman is doing well after she accidentally received six doses of the Pfizer-BioNTech COVID-19 vaccine on Sunday. A health worker at Noa hospital in Tuscany had filled a syringe with an entire vial of the vaccine, which is to be split into six doses. It was only...

FDA Approves 'Significant Step' Toward Ending Pandemic

Pfizer vaccine approved for 12 to 15-year-olds

(Newser) - The first coronavirus vaccine approved for adults and older teens in the US is now the first to gain approval for adolescents as well. The Food and Drug Administration announced Monday that the emergency use authorization for the Pfizer/BioNTech has been expanded to include people 12 to 15 years old....

Pfizer Vaccine for Ages 12 to 15 Expected Soon

FDA on track to give approval by early next week, but could come even sooner

(Newser) - The US Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement...

Millions Are Missing Their Second Dose of COVID Vaccine

Millions are skipping or late for their shot, putting immunity at risk

(Newser) - One is not enough if you’re talking about the Pfizer or Moderna COVID vaccine shots. But millions are skipping their second dose, the New York Times reports. Why? Hard to say for sure, but some people might be choosing to skip it because they feel they have enough protection...

Pfizer: Fake COVID Shots Held Anti-Wrinkle Treatment

Company says counterfeit vaccines have been detected in Mexico, Poland

(Newser) - The combination of people desperate for coronavirus vaccines and worldwide shortages has created an opportunity that criminals are eagerly exploiting, Pfizer warns. The company says it has tested vials seized by investigators in Mexico and Poland and confirmed that phony Pfizer vaccines were involved in both cases, the Wall Street ...

Israeli Study Has Bad News on 'Breakthrough' Infections

South African variant of COVID can break through Pfizer vaccine, it finds

(Newser) - An Israeli study has disheartening news, though researchers are cautioning that more study is needed: The South African coronavirus variant can "break through" and infect those who have received the Pfizer vaccine, the study of around 800 people found. Half of the subjects had tested positive for COVID-19 two...

Pfizer Asks OK for Younger Recipients

FDA approval probably is a few weeks away

(Newser) - Pfizer asked the Food and Drug Administration on Friday to add recipients ages 12 to 15 to the emergency use authorization for its coronavirus vaccine. At the moment, Pfizer has permission to distribute the vaccine for anyone 16 or older. The company said last week that its trials showed its...

Pfizer Vaccine Could Be Nearing 'Full Approval'

Latest data indicates 91.3% efficacy for 6 months

(Newser) - The coronavirus vaccine from Pfizer and BioNTech maintains 91.3% efficacy for at least six months after the second dose, even against the worrisome B.1.351 variant first identified in South Africa, the companies said Thursday. The findings—which double the previous best estimate of 90 days of protection,...

Stories 61 - 80 | << Prev   Next >>